Disease | atrial fibrillation |
Comorbidity | |heart failure |
Sentences | 136 |
PubMedID- 22499333 | Objective: this study assessed the association between the two functional polymorphisms of the beta1-adrenergic receptor gene (adbr1), ser49gly and arg389gly, and the presence of atrial fibrillation in patients with systolic heart failure. |
PubMedID- 24766984 | The same mechanisms that lead to cardiac fibrosis in heart failure may influence development of atrial fibrosis and atrial fibrillation (af). |
PubMedID- 25633056 | Little is known about the outcome of catheter ablation of atrial fibrillation (af) in patients with heart failure (hf) and a severely reduced left ventricular ejection fraction (lvef). |
PubMedID- 23952994 | In our study we compared effect of cardiac resynchronization therapy (crt) in chronic heart failure (chf) patients with permanent atrial fibrillation (af) and patients with sinus rhythm. |
PubMedID- 24390521 | Prediction of congestive heart failure in patients with non valvular atrial fibrillation. |
PubMedID- 22583098 | Case 2 was an 88-year-old woman who had been definitively diagnosed as having ssa-related heart failure with atrial fibrillation two years before. |
PubMedID- 25727992 | heart failure in patients with atrial fibrillation in europe: a report from the eurobservational research programme pilot survey on atrial fibrillation. |
PubMedID- 23568957 | Aims: atrial fibrillation (af) is increased in patients with heart failure resulting from myocardial infarction (mi). |
PubMedID- 23251678 | Introduction: fibroblasts are important in the atrial fibrillation (af) substrate resulting from congestive heart failure (chf). |
PubMedID- 26365943 | Introduction: atrial fibrillation (af) frequently coexists with heart failure (hf). |
PubMedID- 21335470 | Eicosapentaenoic acid prevents atrial fibrillation associated with heart failure in a rabbit model. |
PubMedID- 21684113 | Background: in addition to sudden death, heart failure and stroke due to atrial fibrillation are important in patients with hypertrophic cardiomyopathy (hcm). |
PubMedID- 25919281 | Effect of coenzyme q10 on the incidence of atrial fibrillation in patients with heart failure. |
PubMedID- 23888191 | atrial fibrillation in heart failure: the sword of damocles revisited. |
PubMedID- 22581123 | Management strategies in atrial fibrillation in patients with heart failure. |
PubMedID- 22001955 | A new tissue doppler index in predicting future atrial fibrillation in patients with heart failure. |
PubMedID- 19861229 | A comparison between monophasic and biphasic defibrillation for the cardioversion of persistent atrial fibrillation in patients with and without heart failure. |
PubMedID- 24054473 | Ventricular rate control of atrial fibrillation in heart failure. |
PubMedID- 23916940 | Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction. |
PubMedID- 25639950 | Advanced interatrial block predicts new onset atrial fibrillation in patients with severe heart failure and cardiac resynchronization therapy. |
PubMedID- 20193823 | atrial fibrillation in heart failure: a comprehensive review. |
PubMedID- 24445936 | atrial fibrillation in heart failure: stroke risk stratification and anticoagulation. |
PubMedID- 24039820 | Although some experimental studies support that fish oil may prevent the development of atrial fibrillation (af) associated with heart failure [14], [15], and recent electrophysiologic studies in human also suggests that fish oil supplementation may reduce vulnerability to inducible af [16], [17], results of prospective randomized controlled trials evaluating the effect of fish oil supplementation on poaf are generally controversial [18], [19], [20], [21], [22], [23], [24], [25]. |
PubMedID- 24016492 | Background: even on optimal therapy including anticoagulation and rate control, major cardiovascular complications (stroke, cardiovascular death, and acute heart failure) are common in patients with atrial fibrillation (af). |
PubMedID- 26320296 | [epidemiology and management of heart failure patients with atrial fibrillation]. |
PubMedID- 22886513 | atrial fibrillation (af) worsens outcome in patients with systolic heart failure and the presence of heart failure (hf) predicts a 5- to 6-fold increase in risk of af. |
PubMedID- 23599743 | The aim of this study was to investigate the correlation between the altered expression of genes involved in the regulation of ion channels in atrial myocytes and the risk of atrial fibrillation (af) in patients with heart failure (hf). |
PubMedID- 21421805 | Background: atrial fibrillation (af) is commonly associated with congestive heart failure (chf). |
PubMedID- 19886909 | For example, atrial fibrillation (af) is associated with stroke, thromboembolism, heart failure and impaired quality of life; treatment strategies have largely proved inadequate (thrall et al. |
PubMedID- 22160274 | Impact of chronic atrial fibrillation in patients with severe heart failure and indication for crt: data of two registries with 711 patients (1999-2006 and 2007-6/2008). |
PubMedID- 25305503 | Background: heart failure (hf) is associated with increased atrial fibrillation (af) risk. |
PubMedID- 21923439 | Comparison of rate control versus rhythm control for management of atrial fibrillation in patients with coexisting heart failure: a cost-effectiveness analysis. |
PubMedID- 26341119 | Objective: the use of digoxin in patients having atrial fibrillation (af) with or without heart failure (hf) is not without controversy. |
PubMedID- 23839902 | N-3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: the gissi-hf trial. |
PubMedID- 23631184 | atrial fibrillation (af) is common in patients with heart failure (hf). |
PubMedID- 24054478 | atrial fibrillation in heart failure in the older population. |
PubMedID- 23194489 | Background: heart failure (hf) complicated by atrial fibrillation/flutter (af/afl) is associated with worse outcomes. |
PubMedID- 24054483 | Catheter ablation of atrial fibrillation in heart failure. |
PubMedID- 26097733 | A recent randomized trial (aatac-af) compared catheter ablation with amiodarone for rhythm control of persistent atrial fibrillation in patients with heart failure and cardiomyopathy. |
PubMedID- 23585251 | Aims: in congestive heart failure (chf) patients with persistent atrial fibrillation (af), direct current cardioversion (dcc) may reveal participation of tachycardiamediated process to left ventricular (lv) dysfunction by restoring sinus rhythm (sr). |
PubMedID- 21569543 | In the heart failure-group, the incidence of atrial fibrillation was significantly reduced to 5.6% in the dofetilide-treated patients (hazard ratio 0.57, 95% confidence interval 0.38-0.86). |
PubMedID- 23385332 | Recent advances in management of atrial fibrillation in patients with heart failure. |
PubMedID- 20447580 | Methods and results: we meta-analyzed clinical benefits of crt in heart failure patients with narrow qrs, atrial fibrillation (af) and nyha class ii symptoms. |
PubMedID- 24054474 | Rhythm control of atrial fibrillation in heart failure. |
PubMedID- 22920477 | atrial fibrillation in heart failure: an innocent bystander. |
PubMedID- 24139523 | Background: risk stratification of atrial fibrillation patients with a congestive heart failure (c), hypertension (h), age >/= 75 (a), diabetes (d), stroke or transient ischemic attack (tia) (s2) (chads2) score of <2 remains imprecise, particularly in women. |
PubMedID- 22445594 | Objectives: this study aimed to test the hypothesis that the range of 24-h total heart beats (24 h-thb) correlates with cardiac outcomes (cardiac death and incidence of hospitalization with heart failure) in patients with permanent atrial fibrillation (af). |
PubMedID- 22795713 | Warfarin may reduce risk of ischemic stroke by preventing atrial fibrillation for patients with heart failure and sinus rhythm. |
PubMedID- 25775120 | atrial fibrillation complicated by heart failure induces distinct remodeling of calcium cycling proteins. |
PubMedID- 25364603 | The most common indications for anticoagulation include deep venous thrombosis/pulmonary embolism, congestive heart failure with atrial fibrillation and mitral valve disease with atrial fibrillation. |